GH: Guardant Health, Inc. Common Stock Company Profile & Statistics

Guardant Health, Inc. Common Stock Profile

About

Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. It launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its development programs for recurrence and early detection, LUNAR-1 and LUNAR-2. Guardant Health Inc. is based in REDWOOD CITY, United States.

Info & Links

CEO

Helmy Eltoukhy

Headquarters

3100 Hanover Street
Palo Alto, CA 94304, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

Employees

2,021

Guardant Health, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

11.53B

Enterprise Value

12.07B

Enterprise Value/EBITDA(ttm)

-29.69

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

12.90

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

63.64%

Operating Margin(ttm)

-44.04%

Profit Margin(ttm)

-44.95%

Return on Equity(ttm)

Return on Invested Capital(ttm)

-46.59%

Return on Assets(ttm)

-29.24%

Income Statement

Revenue(ttm)

902.57M

Revenue Per Share(ttm)

7.16

Gross Profit(ttm)

575.46M

EBITDA(ttm)³

-406.46M

Net Income Available to Common(ttm)

-398.79M

Diluted EPS(ttm)

-3.21

Share Statistics

Beta (5Y Monthly)

1.53

52-Week Change

303.24%

S&P 500 52-Week Change

19.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

126.04M

Dividend Yield

0.00%

Float⁴

117.10M

% Held by Insiders

6.10%

% Held by Institutions

92.60%

Balance Sheet

Total Cash(mrq)

580.01M

Total Cash Per Share(mrq)

4.60

Total Debt(mrq)

1.11B

Total Debt/Equity(mrq)

-314.44%

Current Ratio(mrq)

3.50%

Quick Ratio(mrq)

3.35%

Book Value Per Share(mrq)

-2.84

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.27

Free Cash Flow(ytd)

-178.84M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

GH

Guardant Health, Inc. Common Stock